Temple, Texas — According to state and local development sources, BioLife Plasma Services plans to invest $4,000,000.00 to build out 10,011 square feet of new space in Temple. The company plans to occupy the new space at 3817 S. General Bruce Dr. in Temple, on or about November 1, 2023. According to the company website Every day at BioLife, we feel good knowing that what we do helps improve the lives of patients with rare diseases. While you focus on our donors, well support you. We offer a purpose you can believe in, a team you can count on, opportunities for career growth, and a comprehensive benefits program, all in a fast-paced, friendly environment. BioLife Plasma Services is an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies. We operate numerous state-of-the-art plasma collection facilities throughout the United States and Europe. BioLife is committed to safety: through superior service we strive to ensure the safety of our donors and the patients who receive life-saving plasma-based therapeutics. BioLife Plasma Services is part of Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), a patient-focused, values-based, R&D-driven global biopharmaceutical company committed to bringing Better Health and a Brighter Future to people worldwide by translating science into highly-innovative medicines. Our employees are committed to improving quality of life for patients and to working with our partners in health care in approximately 80 countries and regions.

To learn more about BioLife Plasma Services, visit http://www.biolifeplasma.com/

Company Contact:
Hema Tallman, Senior Vice President of Global Operations
https://www.linkedin.com/in/hema-tallman/
224-554-6500

SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.